Relationship of p53 and bcl-2 to Prognosis in Muscle-Invasive Transitional Cell Carcinoma of the Bladder
- 1 May 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (5) , 1754-1757
- https://doi.org/10.1016/s0022-5347(01)66192-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic valueInternational Journal of Cancer, 1993
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- Regulation of the specific DNA binding function of p53Cell, 1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal TranslocationNew England Journal of Medicine, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958